Analysts explain Wall Street’s unfavorable reaction to the Gaithersburg biotech’s new plan for its RSV vaccine candidate for the elderly.
from https://www.bizjournals.com/baltimore/news/2017/07/26/analysts-on-novavax-stock-slide-the-path-forward.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/163444299707
No comments:
Post a Comment